The role of elagolix in ovulation suppression during controlled ovarian stimulation: a retrospective cohort study

Objective: To compare in vitro fertilization treatment outcomes for the oral gonadotropin-releasing hormone (GnRH) antagonist elagolix (E) to the conventionally used injectable GnRH antagonist ganirelix (G) for achieving pituitary gonadotropin suppression during a controlled ovarian stimulation (COS...

Full description

Saved in:
Bibliographic Details
Main Authors: David Soliman, M.Sc., Rita Naoom, B.Sc., Mohamed Zaied, B.Sc., Samuel Soliman, M.D.
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:F&S Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666334124000771
Tags: Add Tag
No Tags, Be the first to tag this record!